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The adrenal medulla is often described as
an enlarged sympathetic ganglion. Its chromaffin .cells,the
analogues of the post ganglionic neurones, release the
neurotransmitter, adrenaline, into the bloodstream in
harmony with a generalised increase in sympathetic nervous
system activity such as occurs in response to stress.
However, I propose to put forward the view,
supported by research done with Dr. Alexander Ungar, that
the regulation of adrenal medullary secretion is far more
complex. Not only is the neural control much more selective
than usually considered but also catecholamine release is
modulated by the surrounding adrenal cortex.
One of the earliest descriptions of the
adrenal glands was made by Eustachius in 1563 and later
Bartholinus (1611) attributed to them the secretion of the
"black bile or atrabile". Uinslow named them the "suprarenal
glands" Although this is an appropriate term for erect
primates,.adrenal is more suitable as they are separate from
but near to the kidneys in other species. The mammalian adrenal
gland consists of an outer cortex and an inner medulla which
are enclosed within the capsule of the gland. The cortex,
synthetising steroid hormones^is under humoral control while
the medulla has a preganglionic sympathetic innervation and
releases the catecholamines, noradrenaline and the methylated
derivative, adrenaline.
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The proportion of these too adrenal catecholamines
varies with species and the human gland contains predominantly
adrenaline while dogs and cats have more equal amounts.
However, noradrenaline was not considered to be an adrenal
catecholamine until 1949 and thus the early work on the
releasing stimuli was only with reference to adrenaline.
This was the situation when Walter B. Cannon
began to formulate his ideas on the emergency role of the
adrenal medulla in stress and put forward the concept of the
sympathetic nervous system as the "flight and fight"
mechanism. A single adrenal hormone fitted in well with his
view that the sympathetic exerted a diffuse and general
influence over the structures which it innervated. He
contrasted the sympatho-adrenal system with the parasympathetic
which, unlike the former system, dealt with organs separately
and not as a group. Cannon described sympatho-adrenal activity
evoking widespread changes, such as dilating pupils, accelerating
the pulse and constricting splanchnic blood vessels while
a reduction in its activity permitted these widely scattered
organs to resume their-farmer state. "Because of their double
innervation the organs under tonic control of the autonomic
system can be made to alter the degree of their functional
use either as an integrated group, through the sympatho¬
adrenal system or as separate structures through the direct







thought and although it is
a useful generalisation,it has hampered the understanding of
the ability of the sympathetic nervous system to respond
selectively. There is good evidence that in a number of reflex
responses,the sympathetic drive to one organ increases uhile
that to another decreases,and is thus not acting^as the
diffuse unselective system which Cannon proposed. For example,
the primary reflex from the arterial chemoreceptors as well,
as stimulating respiration results in peripheral systemic
vasoconstriction uith auithdraul of cardiac sympathetic drive.
However, the increased ventilation invokes the lung stretch
reflex and this reduces vasoconstrictor tone uhile at the
same time increasing sympathetic drive to the heart. (Daly
and Robinson, 1968)
Ue wondered whether the nervous system could
selectively control adrenaline and noradrenaline secretion
from the adrenal medulla or were the two catecholamines
always released in the same proportions. Studies in man were
out of the question for adrenal venous sampling is essential
as the noradrenaline in peripheral blood samples predominantly
originates from adrenergic neurones rather than the adrenal
medulla. Thus most experiments had been performed on dogs
or cats. There was considerable controversy as to whether
independent control of thetvJO catecholamines* release occurred.
In France, Malmejac and his associates had
used dogs and from numerous publications concluded that
noradrenaline and adrenaline were always released in the same
proportions from the adrenal gland.
However, the Scandinavian physiologists
experimented on cats and U.S. von Euler uas their main
spokesman. He argued that various physiological stimuli could
independently release noradrenaline or adrenaline from the
adrenal medulla. He does not appear to have had a very high
opinion of the French workers. In his book "Noradrenaline"(1956)
he refers to only one of their publications and then only uith
regard to their results on resting secretion.
Malrnejac and von Euler presented their opposing
views at the XXI International Congress of Physiological
Sciences in Buenos Aires (1959) and there appears to have
been much debate. Although Flalme j ac urote a Physiological
Review in 1964, his team's work has been largely ignored.
This uas, in part, due to von Euler's prestige but Nalmejac's
case has not been helped by his habit of publishing work
in the form of numerous small and repetitive abstracts in
a relatively inaccessible French journal, Comptes Rendus
de la Societe Biologique.
Over the past twenty five years various
authors have argued for and against selective adrenal
catecholamine release but in all that I have read, no one
has made more than a passing reference to the possibility of
there being a species difference between the dog and the cat.
Although many writers had discussed a great deal of the work
to support one or other view, no one had tried to explain
the controversy by examining the published data to see if
the differences were related to species. Furthermore, no one
laboratory had given the same set of reflex stimuli to both
dogs and cats.
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On examining the literature I found that in the
dog the data suggested that whatever the nature of the stimulus
to the adrenal gland, noradrenaline and adrenaline are released
in about the ratio of>1 to 4. Any claims for independent
secretion of one catecholamine (-it uas always adrenaline)
were based on comparisons with the proportions in very low
resting outputs and one finds that the 1 to 4 ratio held
for the composition of the releases.
However, all those workers who examined adrenal
catecholamine release in cats found evidencejof selective
release. Carotid occlusion and haemorrhage, which exert part
of their effect on the adrenal medulla via the baroreceptor
reflex, give rise to a secretion containing about 1Q% noradrenaline
( Kaindl and von Euler (l95l),von Euler and Folkow (1953) and
Fuerstein and Gutman (1971) ). There is good evidence that
hypoglycaemia releases predominantly adrenaline ( Duner (1954),
Fuerstein and Gutman (1971) ) and from Dun^r's work it
appears that blood glucose exerts its reflex effects only
on adrenaline secretion. .Asphyxia and cyanide-induced
chemoreceptor stimulation seem to preferentially release
adrenaline ( Redgate and Gellhorn (l953);.and Anichkov et al (1960)^
but this work depended on less reliable assays. Stimulation
in the region of the hypothalamus has been shown by three
groups to release adrenaline selectively ( Redgate and
Gellhorn (1953), Folkow and von Euler (1954) and Grant et
al (1958) ). Folkow and von Euler (1954) also found stimulation
points in the brain which selectively released adrenaline
or varying proportions of the two catecholamines.
CAROTID BIFURCATION PERFUSION AND ADRENAL VENOUS BLOOD COLLECTION
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These publications suggested that in cats the
baroreceptor reflex releases.predominantly noradrenaline while
chemoreceptor stimulation releases adrenaline. However,
stimuli like carotid occlus^ion are relatively non-specific
having both baroreceptor and chemoreceptor-ooraponents.
Thus we designed an experimental technique for use in dogs
and cats which would enable us to invoke independently the
baroreceptor reflex from the carotid sinus stretch receptors
and the chemoreceptor reflex from the carotid bodies. The
animals were anaesthetised with chloralose-urethane or
sodium pentobarbitone.
The main arterial^branches of the carotid
sinus regions on both sides were ligated leaving the lingual
arteries open as an outflow which does not have significant
anastomosis with the brain. The vascularly isolated carotid
bifurcations were perfused with the same animal's_arterial
blood delivered at constant pressure by a roller pump.
A servo-amplifier controlled the speed of the pump enabling
the carotid sinus pressure to be set and maintained at will.
The animals were artificially ventilated with air enriched
with oxygen and the pH and PCO2 of arterial blood were held
at normal levels. The vagi were cut in the neck to remove
the buffering effect of the aortic arch receptors.
Baroreceptor reflexes were elicited by lowering the carotid
sinus pressure from 150 to 80 mm Hg. The chemoreceptors were
stimulated by lowering the Po^ of the blood perfusing the
carotid bifurcation.
The venous outflow of the left adrenal gland
was collected for estimation of noradrenaline and adrenaline
(
by a spectrophotofluorimetric method. The percentages of
noradrenaline in the gland's resting secretion an-d in that
released by the baroreceptor and chemoreceptor reflexes uere
calculated. The total amounts of catecholamine in the
incremental releases evoked by the two reflexes were of a
similar size.
In the dogs we consistently found that the
baroreceptor and chemoreceptor reflexes released the same
proportions of noradrenaline and adrenaline as found in the
adrenal gland's resting outputc( i.e. 20/6 noradrenaline ).
However, the situation was very different in
the cats. The resting secretion contained about 45% noradrenaline
while the incremental releases evoked by the baroreceptor and
chemoreceptor reflexes contained 75% and 16% noradrenaline
respectively. ( Critchley et al (1973,1980) ),
Our work explains the apparent controversy
over the existance of selective adrenal catecholamine release.
It is further evidence that the control of the sympathetic
nervous system is much more complex than Cannon proposed.
There is good evidence that noradrenaline and adrenaline
are segregated into separate cells in the adrenal medulla
( Cranko 1958 ). To explain the selective release phenomenom,
I can only presume that the relative proportions of the two
types of cells innervated by the two "sympathetic" reflexes
are different.
Using isolated Locke solution perfused adrenal
glands, ue demonstrated that both muscarinic and rvicotinic
agonist drugs release adrenal catecholamines. In cats but again
not in dogs, ue found that selective release occurred uith
muscarinic and nicotinic stimulation releasing predominantly
adrenaline or noradrenaline respectively,( Critchley et al, 1975 )
Ue found that in the intact animal nicotinic ganglionic
blockade uith hexamethonium selectively abolishes both the
systemic vasoconstriction and adrenal catecholamine release
in response to the baroreceptor reflex but not the chemoreceptor
i —
reflex. From our oun research and that of others, it is
beginning to appear that certain autonomic reflexes have
discrete pathways in the sympathetic nervous system innervating
organs selectively and passing through either predominantly
muscarinic or nicotinic synapses.
However, to return to the adrenal medulla
I have so far only considered neuronal mechanisms of
catecholamine release,. I would now like to discuss the
evidence which led us to believe that there is an important
humoral mechanism. Although it is generally accepted that the
adrenal cortex and medulla function independently, there is
growing evidence that the cortex does exert a significant
influence on the medulla. The very pjhenomenom of their close
association in mammals is strange as embryologically the
medulla originates from neuroectoderm while the cortex is
from coelomic epithelium.
Secondly, there is the existence of the complex
internal circulation of the gland with a portal system carrying
blood rich in steroid hormones to the medulla.
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Thirdly, the work of Shepherd and West (1951)
and Coupland (1953) drew attention to the correlation between
the cortex to medullary size ratio and the percentage of
adrenaline in the glands of various mammalian species.
Flore recently, Pohorecky and Uurtman (1971) have shown
in the rat that the high concentration of glucocorticoids
delivered to the medulla from the cortex is essential for
the maintenance of the enzyme, Phenylethenolamine-N-methyl
transferase (PNFIT) which methylates noradrenaline to
adrenaline.
Finally, there is a little evidence from
studies on adrenal gland catecholamine content-that
corticotrophin administration results in the depletion of
adrenaline but not noradrenaline,( Houssay et al (1933) and
Eranko (1952) ).
The blood supply to the medulla is from two
main sources. There are the capillary channels of the cortical
zona reticularis which become the sinusoids of the medulla.
Also the arteriae medullae pass through the cortex from
the "capsular" plexus before breaking up into capillary
channels which form a network around adjacent chromaffin cells.
Capillary blood vessels derived primarily from the arteriae
medullae anastomose with each other and the branches of the
venous tree ( Flint, 1900 ). Thus not all the blood flowing
through the arteriae medullae enters the cortico-medullary
sinuses as it can also pass directly to the .central vein
through the venae medullae.
The anatomy of the musculature of the adrenal
blood vessels is complex and not fully understood but one
uonders if it could alter the distribution of flow between the
cortico-medullary sinusoids and the arteriae medullae. This
would change the concentration of glucocorticoids bathing
the medullary cells.
Uhen Shepherd and LJest (1951) surveyed the
percentage of adrenaline in the adrenal medulla of various
mammalian and avian species they found a good correlation
with the ratio of the volume of cortical to medullary tissue.
In species where this ratio is high,such as in the cavy
and rabbit, the medulla contains almost exclusively adrenaline
while in those with a lower ratio, such as the cat and dog,
a greater percentage of noradrenaline is found. Moreover,
the medulla of foetal mammals contains very little adrenaline
and the adrenal content of this catecholamine rises sharply
after birth in parallel with a period of marked cortical
development. The dependence of methylation on the cortex
only appears to be the case in mammals. Other vertebrates
which have separate steroid hormone and catecholamine
synthetising tissues, have chromaffin glands containing a
large proportion of adrenaline (Shepherd, West and Erspaner, 1953)
Pohorecky and Uurtman (1971) have established
that in the mammalian adrenal medulla, the maintenance of
the PNMT enzyme depends on the delivery of a high concentration
of glucocorticoids via the cortiomedullary portal system.
Their evidence is summarised in two reviews (1971, 1972) and
I shall now mention the salient features.
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Most of the studies were done in rats.
Hypophysectomy results in a rapid fall in medullary PNMT
activity uith a half life of three to five days.
This activity is restored by corticotrophin administration
but not glucocorticoid maintenance therapy.
Enzyme activity only begins to be restored by the administration
of amounts of glucocorticoids which give peripheral arterial
concentrations fifty to one hundred times normal.
Thus the high concentrations of glucocorticoids found in the
adrenal medulla ( one hundred to tuo hundred times peripheral
concentrations ) appear to be necessary for the maintenance
of PNMT and the mechanism-is thought to be related to the
synthesis of the enzyme protein.
Other classes of steroid hormones do not appear to have
a physiological action on PNMT activity.
Houever, it is. noteworthy that they base little of their
argument on the actual catecholamine content of these glands.
This is, no doubt, because they found that changes in
catecholamine content lag behind the changes in enzyme activity.
After hypophysectomy, adrenaline content does decline but uith
noradrenaline
a half life of thirty to eighty days uhile/does show an increase
but not in proportion to the fall in adrenaline. Houever,
radioactive tracer studies have shoun that the half life of
adrenaline in intact rat adrenal medulla is seven to fourteen
days ( Udenfriend and Uyngaarden, 1956 ).
The discrepancy between the half life of
adrenaline in intact and hypophysectomised animals can be
explained by postulating that adrenaline synthesis still
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continues at a near normal r
PNMT levels found after one
simpler explaination is that
considerably reduced.
ate in spite of the very lou
to tuo weeks. However, a much
the release of adrenaline is
Ue decided to investgate whether there is
such a humoral component to adrenal catecholamine release.
Our studies were all done in dogs, usually greyhounds or
crossbred collies.
Ue found that intravenous Synacthen (cortico-
trophin-like peptide) resulted in a prolonged release of
adrenal catecholamines from both intact and denervated glands.
Chemoreceptor stimulation has been shown to
cause reflex release of corticotrophin from the anterior
pituitary gland resulting in a high output of corticosteroids
from the adrenal .cortex ( Anichkov et al(l960) and Marotta (1972)
Ue wondered whether the pituitary-adrenobortical axis could
be involved in the response of the adrenal medulla to
chemoreceptor stimulation. Using prolonged chemoreceptor
stimulation lasting ten to twenty minutes, we found that
as well as the expected immediate neuronally mediated
catecholamine release, there was also a delayed component
which was still present after denervation of the gland.
This release occurred seven to ten minutes after commencement
of chemoreceptor stimulation and had a magnitude and prolonged
time course similar to that seen with Synacthen administration.
The delayed release of catecholamines in
response to both Synacthen and chemoreceptor stimulation was
inhibited by cycloheximide which has been shown to block
steroid hormone secretion ( Garren, Ney and Davies, 1965 ).
Houever, cycloheximide had no effect on the immediate
neuronally mediated medullary release in response to
chemoreoeptor or baroreceptor reflex stimulation.
r
Furthglnore the drug had no effect on the catecholamine output
from isolated perfused adrenal glands.
Finally ue demonstrated that hydrocortisone
in the concentrations expected in the adrenal gland during
stress increased the catecholamine output from isolated
Locke solution perfused adrenal glands in a dose dependent
manner.
Thus ue concluded that a humoral mechanism
involving the anterior pituitary - adrenal cortical axis
can release adrenal medullary catecholamines ( Critchley and
L)ngar( 1974) , Critchley et al( 1975, 1981) ).
In our anaesthetised animals ue found that a
Po2 of tuenty to thirty torr uas required to activate the
neuronal reflex uhile the humoral mechanism uas elicited by
less severe but prolonged hypoxia in the region of fifty torr,
Anaesthesia is knoun to depress reflexes and thus in the
non-anaesthetised animal ue uould expect to find that the
reflexes are activated by milder hypoxia. The louer threshold
for the humoral mechanism and evidence in the literature
uhich I have already discussed,suggests that the adrenal
cortex exerts a tonic influence on medullary catecholamine
output. This might even explain,by a process of feedback
induction,the dependence of the methylating enzyme on the
integrity of the anterior pituitary — adrenal cortical axis*
In conclusion, I propose that the body has
at least three mechanisms through which the adren-al glands
respond to a stress such as hypoxia.
Firstly, there is the humoral pathway
involving the anterior pituitary - adrenocortical axis.
This comes into play with mild prolonged hypoxia.
Uith more severe hypoxia there is the neuronal
reflex which can respond rapidly in the emergency situation.
Finally there is the possibility of a direct
effect of hypoxia acting locally on the adrenal medulla.
This last mechanism is probably of little physiological
significance except under extreme circumstances such as
asphyxia.
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